CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wacholder, S.
Right arrow Articles by Hartge, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wacholder, S.
Right arrow Articles by Hartge, P.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 885-889, September 2002
© 2002 American Association for Cancer Research

Joint Effect of Genes and Environment Distorted by Selection Biases

Implications for Hospital-based Case-Control Studies

Sholom Wacholder1, Nilanjan Chatterjee and Patricia Hartge

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20892-7244

The hospital-based case-control design enhances the response rates in studies that require the collection of biological samples from all of the participants. There are simple, established criteria for selecting controls so as to estimate the effect of a single factor without bias, but the analogous requirements for assessing an interaction are less clear. We derive these conditions by calculating the potential bias from selecting controls who were admitted for treatment of diseases related to either or both of the exposures of interest, designated as a gene variant (G) and an environmental agent (E). There is no bias in the estimate of the effect of E when G is associated with the control condition, whether causally or because of confounding. There is no bias in estimating multiplicative interaction between G and E for the disease of interest when there is no multiplicative G-E interaction for the control disease, even when the control condition is caused by G or E; if a mixture of several control diseases are used, however, the absence of G-E interaction in each individual disease does not ensure a lack of overall bias when controls are pooled. Hospital control designs are much less robust for assessing additive interaction. We conclude that the ideal control disease in a hospital-based study of gene-environment interaction is not caused by either G or E and that choosing controls from several conditions to act as a combined control group is a useful strategy. This formulation extends to the general problem of distortion of joint effects from selection biases or confounding.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Negri, R. Talamini, M. Montella, L. Dal Maso, A. Crispo, M. Spina, C. La Vecchia, and S. Franceschi
Family History of Hemolymphopoietic and Other Cancers and Risk of Non-Hodgkin's Lymphoma.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 245 - 250.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Herrington
Eliminating the Improbable: Sherlock Holmes and Standards of Evidence in the Genomic Age
Circulation, October 4, 2005; 112(14): 2081 - 2084.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. M. Morimoto, E. White, and P. A. Newcomb
Selection Bias in the Assessment of Gene-Environment Interaction in Case-Control Studies
Am. J. Epidemiol., August 1, 2003; 158(3): 259 - 263.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.